ANDA 210097, held by Strides Pharma. Potassium Chloride.
As of Nov 15, 2026, ANDA 210097 (Potassium Chloride), held by Strides Pharma, was first approved by FDA on Jun 17, 2019, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 17, 2019 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Potassium Chloride10MEQ ยท tablet, extended release;oral | Potassium Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
